TMEM127 p.Ser30Gly

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2

The NM_017849.4(TMEM127):​c.88A>G​(p.Ser30Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00032 in 1,552,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S30R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 0 hom. )

Consequence

TMEM127
NM_017849.4 missense

Scores

2
9
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 4.33

Publications

0 publications found
Variant links:
Genes affected
TMEM127 (HGNC:26038): (transmembrane protein 127) This gene encodes a transmembrane protein with four predicted transmembrane domains. The protein is associated with a subpopulation of vesicular organelles corresponding to early endosomal structures, with the Golgi, and with lysosomes, and may participate in protein trafficking between these structures. Mutations in this gene and several other genes cause pheochromocytomas. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2022]
TMEM127 Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_017849.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.40699703).
BP6
Variant 2-96265294-T-C is Benign according to our data. Variant chr2-96265294-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 405201.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000344 (482/1400576) while in subpopulation NFE AF = 0.000434 (472/1087624). AF 95% confidence interval is 0.000401. There are 0 homozygotes in GnomAdExome4. There are 220 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 15 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017849.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMEM127
NM_017849.4
MANE Select
c.88A>Gp.Ser30Gly
missense
Exon 2 of 4NP_060319.1O75204
TMEM127
NM_001193304.3
c.88A>Gp.Ser30Gly
missense
Exon 2 of 4NP_001180233.1O75204
TMEM127
NM_001407283.1
c.-9+575A>G
intron
N/ANP_001394212.1C9J4H2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMEM127
ENST00000258439.8
TSL:1 MANE Select
c.88A>Gp.Ser30Gly
missense
Exon 2 of 4ENSP00000258439.3O75204
TMEM127
ENST00000432959.2
TSL:1
c.88A>Gp.Ser30Gly
missense
Exon 2 of 4ENSP00000416660.1O75204
TMEM127
ENST00000910913.1
c.88A>Gp.Ser30Gly
missense
Exon 1 of 3ENSP00000580972.1

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
15
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000599
AC:
9
AN:
150266
AF XY:
0.0000726
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000147
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000344
AC:
482
AN:
1400576
Hom.:
0
Cov.:
31
AF XY:
0.000318
AC XY:
220
AN XY:
692898
show subpopulations
African (AFR)
AF:
0.0000929
AC:
3
AN:
32286
American (AMR)
AF:
0.00
AC:
0
AN:
37640
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25296
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36702
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80618
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36470
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5500
European-Non Finnish (NFE)
AF:
0.000434
AC:
472
AN:
1087624
Other (OTH)
AF:
0.000120
AC:
7
AN:
58440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152210
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68022
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.0000718

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
1
not provided (2)
-
1
-
Hereditary pheochromocytoma and paraganglioma (1)
-
1
-
Pheochromocytoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Uncertain
0.042
T
BayesDel_noAF
Uncertain
0.080
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.068
T
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.83
T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.41
T
MetaSVM
Uncertain
-0.15
T
MutationAssessor
Benign
1.7
L
PhyloP100
4.3
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.48
Sift
Benign
0.034
D
Sift4G
Benign
0.18
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.45
gMVP
0.83
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs763476625;
hg19: chr2-96931032;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.